Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohamed Labib

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Immunological Investigations|November 29, 2017
High numbers of myeloid derived suppressor cells in peripheral blood and ascitic fluid of cirrhotic and HCC patientsNadia Elwan, Mohamed Labib Salem, Abdelrahman Kobtan, et al.
Surgical Neurology International|September 3, 2020
The anterior incisural width as a preoperative indicator for intradural space evaluation: An anatomical investigationXiaochun Zhao, Mohamed Labib, Dinesh Ramanathan, et al.
Antimicrobial Agents and Chemotherapy|August 31, 2006
Critical design features of phenyl carboxylate-containing polymer microbicidesRobert F Rando, Sakae Obara, Mark C Osterling, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2004
Mouse model of cervicovaginal toxicity and inflammation for preclinical evaluation of topical vaginal microbicidesBradley J Catalone, Tina M Kish-Catalone, Lynn R Budgeon, et al.
Microbial Biotechnology|September 7, 2020
Screening of a genome-reduced Corynebacterium glutamicum strain library for improved heterologous cutinase secretionJohannes Hemmerich, Mohamed Labib, Carmen Steffens, et al.
Scientific Reports|March 12, 2021
An ex vivo model of medical device-mediated bacterial skin translocationHao Wang, Anant Agrawal, Yi Wang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 26, 2010
Structure-activity relationships of polybiguanides with activity against human immunodeficiency virus type 1Shendra R Passic, Mary Lee Ferguson, Bradley J Catalone, et al.
Molecular Biology Reports|May 21, 2020
MicroRNA signature in hepatocellular carcinoma patients: identification of potential markersMohammed Elhendawy, Enas A Abdul-Baki, Sherief Abd-Elsalam, et al.
Molecular Biology Reports|June 12, 2020
Correction to: MicroRNA signature in hepatocellular carcinoma patients: identification of potential markersMohammed Elhendawy, Enas A Abdul-Baki, Sherief Abd-Elsalam, et al.
Immunopharmacology and Immunotoxicology|May 6, 2017
IFN-α-based treatment of patients with chronic HCV show increased levels of cells with myeloid-derived suppressor cell phenotype and of IDO and NOSMohamed Labib Salem, Abdel-Aziz A Zidan, Mohamed Attia, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Immunological Investigations|November 29, 2017
High numbers of myeloid derived suppressor cells in peripheral blood and ascitic fluid of cirrhotic and HCC patientsNadia Elwan, Mohamed Labib Salem, Abdelrahman Kobtan, et al.
Surgical Neurology International|September 3, 2020
The anterior incisural width as a preoperative indicator for intradural space evaluation: An anatomical investigationXiaochun Zhao, Mohamed Labib, Dinesh Ramanathan, et al.
Antimicrobial Agents and Chemotherapy|August 31, 2006
Critical design features of phenyl carboxylate-containing polymer microbicidesRobert F Rando, Sakae Obara, Mark C Osterling, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2004
Mouse model of cervicovaginal toxicity and inflammation for preclinical evaluation of topical vaginal microbicidesBradley J Catalone, Tina M Kish-Catalone, Lynn R Budgeon, et al.
Microbial Biotechnology|September 7, 2020
Screening of a genome-reduced Corynebacterium glutamicum strain library for improved heterologous cutinase secretionJohannes Hemmerich, Mohamed Labib, Carmen Steffens, et al.
Scientific Reports|March 12, 2021
An ex vivo model of medical device-mediated bacterial skin translocationHao Wang, Anant Agrawal, Yi Wang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 26, 2010
Structure-activity relationships of polybiguanides with activity against human immunodeficiency virus type 1Shendra R Passic, Mary Lee Ferguson, Bradley J Catalone, et al.
Molecular Biology Reports|May 21, 2020
MicroRNA signature in hepatocellular carcinoma patients: identification of potential markersMohammed Elhendawy, Enas A Abdul-Baki, Sherief Abd-Elsalam, et al.
Molecular Biology Reports|June 12, 2020
Correction to: MicroRNA signature in hepatocellular carcinoma patients: identification of potential markersMohammed Elhendawy, Enas A Abdul-Baki, Sherief Abd-Elsalam, et al.
Immunopharmacology and Immunotoxicology|May 6, 2017
IFN-α-based treatment of patients with chronic HCV show increased levels of cells with myeloid-derived suppressor cell phenotype and of IDO and NOSMohamed Labib Salem, Abdel-Aziz A Zidan, Mohamed Attia, et al.
Pageof 9